D
Dyne Therapeutics, Inc. DYN
$14.20 $0.211.50% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income -42.63% -34.54% -41.51% -36.08% -45.67%
Total Depreciation and Amortization 8.62% 0.00% -3.16% -1.58% -1.38%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 3.81% 116.51% 113.11% 111.04% 106.06%
Change in Net Operating Assets 595.36% -174.09% 87.45% 138.81% -83.42%
Cash from Operations -45.47% -55.38% -33.29% -25.48% -46.71%
Capital Expenditure -358.84% -225.93% -18.61% 31.19% 63.61%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 84.04% -340.00% -307.03% -209.63% -203.89%
Cash from Investing 81.57% -344.96% -312.00% -212.55% -206.18%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 25.09% 1,390.92% 782.49% 766.93% 555.56%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 25.09% 1,390.92% 782.49% 766.93% 555.56%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 121.21% 720.39% 2,847.34% 1,291.43% 176.20%